cfDNA Assay Multicenter Prospective Observational Validation for Early Cancer Detection, Minimal Residual Disease, and Relapse (CAMPERR)
- Sponsor:
- Adela, Inc.
- Sponsor Study ID:
- Adela-EDMRD-001
- CTO #:
- 104206
- NCT Number:
- NCT05366881
- Phase:
- N/A
- Protocol Type:
- Diagnostic
- Age Group:
- Adults
- Disease Sites:
- Lung
- Study Objectives:
- The primary objective of this study is to train and validate the methylome profiling platform to discriminate cancer from non- cancer.
- eConsent:
- Not available
- Study Documents:
-
Open Study Documents
(MUSC NetID required for document access)
For more information about this trial please contact the study team:
-
Medical University of South Carolina
- Principal Investigator, Silvestri, Gerard, at silvestr@musc.edu .
- Study Coordinator, Balassone, Michael, at balassom@musc.edu .
Trial opened at the following institutions:
Medical University of South Carolina